Clinical Trials Browser

Completed × Liver Neoplasms × Melphalan × Clear all

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT00019786 2012-03-23

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Colonic Neoplasms, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Liver Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Islet Cell, Carcinoma, Neuroendocrine

NCT00001576 2008-03-04

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Phase 1 Completed

28 enrolled

Gastrointestinal

Hyperthermia, Liver Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT00001587 2008-03-04

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver

Phase 1 Completed

30 enrolled

Gastrointestinal

Hyperthermia, Liver Neoplasms, Neoplasm Metastasis

Clinical Trials

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver